February 2026

The BioPharma industry is in rapid flux, shaped by transforming drug pipelines, the ongoing political battle over lowering drug prices, and a new rebate model for the 340B Drug Discount program. Here’s what’s shaping the latest in healthcare. Source: BioPharma International In a recent BioPharm International interview, Janice MacLennan, founder Read more…